Find Therapeutics Announces First Subject Dosed in Phase 1 Clinical Study of FTX-101

202220232024
Written By Guest User

Find Therapeutics Announces First Subject Dosed in Phase 1 Clinical Study of FTX-101

Guest User
Previous

Epitopea conclut des ententes de financement préalable à la série A d’un montant de 31 millions de dollars US
Next

AstraZeneca Closes Acquisition of Amolyt Pharma